45 / 86
Study 309
: Randomized, open-label, multicenter, phase 3
study of eribulin versus dacarbazine in patients with
leiomyosarcoma (LMS) and adipocytic sarcoma (ADI):
Subgroup Analysis
SP Chawla, S Patel, E Choy, V Gruenwald,
P Hohenberger, D D’Adamo, R Chen, G
Grignani, R Jones, P Schöffski, RG
Maki
Chawla SP, et al. Presented at CTOS 2015 Annual Meeting, Salt Lake City, UT, November 4-7, 2015